Loading the security overview…
Where the tokens are
First the companies classified under the same themes, most themes in common first; then the ones investors most often look at alongside ZBH. A peer with a tokenized version links to its own page, where every issuer that wraps it is listed.
| Company | Shared themes | Market cap | P/E | P/S | EV/EBITDA | ROE | F-Score | Altman zone |
|---|---|---|---|---|---|---|---|---|
| — | $16.8B | 20.8 | 2.0 | 9.6 | 6.4% | 6/9 | safe | |
| Age-Related TherapeuticsOrthopedic & Implantable Devices | $918.7M | 16.1 | 1.6 | 10.8 | 25.1% | 8/9 | grey | |
| Age-Related Therapeutics | $209.99B | — | — | — | — | — | — | |
| Age-Related Therapeutics | $110.57B | 21.1 | 3.0 | 13.6 | 10.4% | 7/9 | safe | |
| Age-Related Therapeutics | $49.1B | 48.9 | 7.5 | 23.6 | 9.5% | 6/9 | safe | |
| Age-Related Therapeutics | $32.92B | 39.5 | 3.3 | 17.3 | 4.4% | 5/9 | safe | |
| Age-Related Therapeutics | $30.91B | 70.3 | 3.6 | 31.8 | 2.3% | 7/9 | safe | |
| Orthopedic & Implantable Devices | $10.92B | 19.1 | 2.6 | 14.3 | 6.9% | 7/9 | safe | |
| Orthopedic & Implantable Devices | $10.33B | 25.0 | 2.5 | 10.6 | 9.8% | 7/9 | safe | |
| Orthopedic & Implantable Devices | $9.99B | 18.7 | 3.2 | 9.9 | 11.2% | 8/9 | safe | |
| Age-Related Therapeutics | $9.62B | — | 15.7 | -63.3 | −27.6% | 3/9 | safe | |
| Age-Related Therapeutics | $6.05B | — | 1.1 | 12.4 | −2.7% | 3/9 | distress | |
| Orthopedic & Implantable Devices | $3.72B | 39.2 | 1.3 | 10.4 | 3.1% | 7/9 | safe | |
| Age-Related Therapeutics | $3.28B | — | 910.6 | -5.8 | −61.4% | 3/9 | safe | |
| Orthopedic & Implantable Devices | $2.28B | 31.6 | 3.6 | 20.6 | 15.6% | 7/9 | safe |
Figures describe Zimmer Biomet shares, not any token. From theme classifications, Massive's related companies and the latest ratios and scores. Ratios are trailing, each as of its own latest filing. Peers are for comparison, not a list of alternatives to buy.